BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38757078)

  • 1. Consolidative Proton Radiotherapy for Pediatric Extramedullary Ocular Acute Myeloid Leukemia.
    Bush A; Eslin DE; Joyce MJ; Hess D; Leon D; Ermoian RP; Mailhot Vega RB
    Int J Part Ther; 2024 Mar; 11():100002. PubMed ID: 38757078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia.
    Ladbury C; Semwal H; Hong D; Yang D; Hao C; Han C; Liu A; Marcucci G; Rosenthal J; Hui S; Salhotra A; Ali H; Nakamura R; Stein A; Al Malki M; Wong JYC; Dandapani S
    Front Oncol; 2022; 12():1017355. PubMed ID: 36387179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche.
    Patel SA; Bledsoe JR; Gordon J; Cerny J
    Acta Haematol; 2021; 144(3):297-301. PubMed ID: 32814320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia.
    Byrd JC; Edenfield WJ; Dow NS; Aylesworth C; Dawson N
    Leuk Lymphoma; 1996 Mar; 21(1-2):153-9. PubMed ID: 8907283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of extramedullary leukemia as a presentation of acute myeloid leukemia.
    Slomowitz SJ; Shami PJ
    J Natl Compr Canc Netw; 2012 Sep; 10(9):1165-9. PubMed ID: 22956813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Conjunctival Infiltration as an Extramedullary Relapse of AML.
    Mozaheb Z; Khooei A
    Case Rep Hematol; 2018; 2018():9590469. PubMed ID: 29619260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extramedullary acute myelogenous leukemia.
    Solh M; Solomon S; Morris L; Holland K; Bashey A
    Blood Rev; 2016 Sep; 30(5):333-9. PubMed ID: 27094614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma.
    Figura NB; Flampouri S; Hopper K; Marcus RB; Mendenhall NP; Hoppe BS
    J Adolesc Young Adult Oncol; 2011 Jun; 1(2):103-6. PubMed ID: 26812632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
    Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
    Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary relapse of acute myeloid leukemia in brachial plexus after allogeneic stem cell transplantation: a case report.
    Shirota S; Katoh D; Shimomura Y; Imai Y; Ishikawa T
    BMC Neurol; 2022 Jul; 22(1):241. PubMed ID: 35778695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved.
    Shallis RM; Gale RP; Lazarus HM; Roberts KB; Xu ML; Seropian SE; Gore SD; Podoltsev NA
    Blood Rev; 2021 May; 47():100773. PubMed ID: 33213985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
    Huang YJ; Zhang JH; Dong CX; Kang JM; Hou YF; Zhang YF; Qi K; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1361-1368. PubMed ID: 36208236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes.
    Sabnis HS; Minson KA; Monroe C; Allen K; Metts JL; Cooper TM; Woods WG; Castellino SM; Keller FG
    Leuk Res; 2020 Sep; 96():106421. PubMed ID: 32683126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study.
    Garnham A; Bruon F; Berthon C; Lebon D; Parimi M; Polya R; Makhloufi KM; Dramard-Goasdoue MH
    Oncol Ther; 2023 Sep; 11(3):375-389. PubMed ID: 37578642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
    Koc Y; Miller KB; Schenkein DP; Daoust P; Sprague K; Berkman E
    Cancer; 1999 Feb; 85(3):608-15. PubMed ID: 10091734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study.
    Lee JW; Yoo JW; Kim S; Jang PS; Chung NG; Cho B
    Cancer Res Treat; 2022 Oct; 54(4):1230-1239. PubMed ID: 34922415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia.
    Kunadt D; Kramer M; Dill C; Altmann H; Wagenführ L; Mohr B; Thiede C; Röllig C; Schetelig J; Bornhäuser M; Schaich M; Stölzel F
    Biomark Res; 2020; 8():20. PubMed ID: 32537166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.